Belite Bio Adr Stock Alpha and Beta Analysis

BLTE Stock  USD 164.58  4.73  2.96%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Belite Bio ADR. It also helps investors analyze the systematic and unsystematic risks associated with investing in Belite Bio over a specified time horizon. Remember, high Belite Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Belite Bio's market risk premium analysis include:
Beta
(0.73)
Alpha
1.03
Risk
4.14
Sharpe Ratio
0.24
Expected Return
0.99
Please note that although Belite Bio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Belite Bio did 1.03  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Belite Bio ADR stock's relative risk over its benchmark. Belite Bio ADR has a beta of 0.73  . As returns on the market increase, returns on owning Belite Bio are expected to decrease at a much lower rate. During the bear market, Belite Bio is likely to outperform the market. At present, Belite Bio's Tangible Book Value Per Share is projected to slightly grow based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 12.49, whereas Enterprise Value Over EBITDA is forecasted to decline to (64.18).

Enterprise Value

1.79 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Belite Bio Backtesting, Belite Bio Valuation, Belite Bio Correlation, Belite Bio Hype Analysis, Belite Bio Volatility, Belite Bio History and analyze Belite Bio Performance.

Belite Bio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Belite Bio market risk premium is the additional return an investor will receive from holding Belite Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Belite Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Belite Bio's performance over market.
α1.03   β-0.73

Belite Bio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Belite Bio's Buy-and-hold return. Our buy-and-hold chart shows how Belite Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Belite Bio Market Price Analysis

Market price analysis indicators help investors to evaluate how Belite Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Belite Bio shares will generate the highest return on investment. By understating and applying Belite Bio stock market price indicators, traders can identify Belite Bio position entry and exit signals to maximize returns.

Belite Bio Return and Market Media

The median price of Belite Bio for the period between Mon, Oct 27, 2025 and Sun, Jan 25, 2026 is 149.13 with a coefficient of variation of 18.22. The daily time series for the period is distributed with a sample standard deviation of 24.65, arithmetic mean of 135.27, and mean deviation of 22.28. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Belite Bio Valuation Insights After UK Green Lights Tinlarebants Conditional Marketing Review for Stargardt Disease
11/04/2025
2
Belite Bio initiated with a Neutral at Mizuho - TipRanks
11/20/2025
3
Virtus Investment Advisers LLC Sells 1,076 Shares of Belite Bio, Inc. Sponsored ADR BLTE
12/01/2025
4
A Look at Belite Bio Valuation Following Positive Tinlarebant Phase 3 Trial Results
12/02/2025
5
Belite Bio Reaches New 52-Week High - Should You Buy - MarketBeat
12/12/2025
6
Belite Bio Sets New 1-Year High - Heres Why - MarketBeat
12/18/2025
7
Belite Bio Sets New 12-Month High - Time to Buy - MarketBeat
12/30/2025
8
Belite Bio stock hits all-time high at 169.88 USD By Investing.com - Investing.com Nigeria
01/09/2026

About Belite Bio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Belite or other stocks. Alpha measures the amount that position in Belite Bio ADR has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Belite Bio Upcoming Company Events

As portrayed in its financial statements, the presentation of Belite Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Belite Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Belite Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Belite Bio. Please utilize our Beneish M Score to check the likelihood of Belite Bio's management manipulating its earnings.
29th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Belite Bio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:
Check out Belite Bio Backtesting, Belite Bio Valuation, Belite Bio Correlation, Belite Bio Hype Analysis, Belite Bio Volatility, Belite Bio History and analyze Belite Bio Performance.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Belite Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Belite Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Belite Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...